Efficacy and safety of autologous stem cell transplantation in first-line treatment and at relapse in elderly patients with multiple myeloma

INTRODUCTION: Although recent data suggest that melphalan high-dose therapy followed by autologous stem cell transplantation (HDT/ASCT) is safe and effective in eligible multiple myeloma (MM) patients up to the age of 75 years, its value in elderly MM patients is still controversially discussed. - M...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Klein, Eva-Maria (VerfasserIn) , Hujic, Sejla (VerfasserIn) , Miah, Kaya (VerfasserIn) , Benner, Axel (VerfasserIn) , Merz, Maximilian (VerfasserIn) , Bertsch, Uta (VerfasserIn) , Weinhold, Niels (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn) , Sauer, Sandra (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: October 3, 2024
In: Oncology
Year: 2025, Jahrgang: 103, Heft: 5, Pages: 389-399
ISSN:1423-0232
DOI:10.1159/000541541
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1159/000541541
Volltext
Verfasserangaben:Eva-Maria Klein, Sejla Hujic, Kaya Miah, Axel Benner, Maximilian Merz, Uta Bertsch, Niels Weinhold, Hartmut Goldschmidt, Sandra Sauer

MARC

LEADER 00000caa a2200000 c 4500
001 1928200109
003 DE-627
005 20260126175628.0
007 cr uuu---uuuuu
008 250613s2025 xx |||||o 00| ||eng c
024 7 |a 10.1159/000541541  |2 doi 
035 |a (DE-627)1928200109 
035 |a (DE-599)KXP1928200109 
035 |a (OCoLC)1559702007 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Klein, Eva-Maria  |e VerfasserIn  |0 (DE-588)1220814547  |0 (DE-627)1737787024  |4 aut 
245 1 0 |a Efficacy and safety of autologous stem cell transplantation in first-line treatment and at relapse in elderly patients with multiple myeloma  |c Eva-Maria Klein, Sejla Hujic, Kaya Miah, Axel Benner, Maximilian Merz, Uta Bertsch, Niels Weinhold, Hartmut Goldschmidt, Sandra Sauer 
264 1 |c October 3, 2024 
300 |b Illustrationen 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.06.2025 
520 |a INTRODUCTION: Although recent data suggest that melphalan high-dose therapy followed by autologous stem cell transplantation (HDT/ASCT) is safe and effective in eligible multiple myeloma (MM) patients up to the age of 75 years, its value in elderly MM patients is still controversially discussed. - METHODS: We retrospectively analyzed 607 MM patients ≥60 years old, who were admitted to our institution for first-line or salvage HDT/ASCT between January 2007 and October 2018. We assigned them to three groups according to age at HDT/ASCT: 60-64 years (S1), 65-69 years (S2) and ≥70 years (S3). We compared progression-free and overall survival, duration of hospitalization, complications, transfers to intermediate or intensive care unit, readmissions after discharge and deaths within 100 days after HDT/ASCT between these groups. - RESULTS: Age did not impact progression-free and overall survival after first-line and salvage HDT/ASCT. Patients ≥70 years old at first HDT/ASCT had a longer hospitalization compared to patients 60-64 years old; however, the difference in the length of hospitalization was only marginal. Rates of febrile neutropenia, mucositis, transfers to intermediate or intensive care unit, readmissions after discharge, and deaths within 100 days after HDT/ASCT were similar in the 3 age groups of patients receiving first or salvage HDT/ASCT. Patients with a Charlson Comorbidity Index ≥2 receiving first HDT/ASCT had a higher risk for a transfer to intermediate or intensive care unit. - CONCLUSION: Our analysis shows that HDT/ASCT is safe and effective in eligible elderly MM patients in first-line treatment and at relapse. A careful patient selection according to biological rather than chronological age is of crucial importance. 
650 4 |a Age Factors 
650 4 |a Aged 
650 4 |a Autologous stem cell transplantation 
650 4 |a Elderly patients 
650 4 |a Female 
650 4 |a Hematopoietic Stem Cell Transplantation 
650 4 |a Humans 
650 4 |a Male 
650 4 |a Melphalan 
650 4 |a Middle Aged 
650 4 |a Multiple myeloma 
650 4 |a Multiple Myeloma 
650 4 |a Neoplasm Recurrence, Local 
650 4 |a Retrospective Studies 
650 4 |a Salvage Therapy 
650 4 |a Survival 
650 4 |a Toxicity 
650 4 |a Transplantation, Autologous 
650 4 |a Treatment Outcome 
700 1 |a Hujic, Sejla  |e VerfasserIn  |4 aut 
700 1 |a Miah, Kaya  |e VerfasserIn  |0 (DE-588)1387997181  |0 (DE-627)195024055X  |4 aut 
700 1 |a Benner, Axel  |d 1959-  |e VerfasserIn  |0 (DE-588)106584686X  |0 (DE-627)81687221X  |0 (DE-576)425536602  |4 aut 
700 1 |a Merz, Maximilian  |d 1985-  |e VerfasserIn  |0 (DE-588)1023626950  |0 (DE-627)718419278  |0 (DE-576)367168251  |4 aut 
700 1 |a Bertsch, Uta  |e VerfasserIn  |0 (DE-588)1026849861  |0 (DE-627)727494163  |0 (DE-576)372176224  |4 aut 
700 1 |a Weinhold, Niels  |e VerfasserIn  |0 (DE-588)141225688  |0 (DE-627)626149576  |0 (DE-576)322607388  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Sauer, Sandra  |d 1975-  |e VerfasserIn  |0 (DE-588)1060031140  |0 (DE-627)799171778  |0 (DE-576)416132855  |4 aut 
773 0 8 |i Enthalten in  |t Oncology  |d Basel : Karger, 1967  |g 103(2025), 5 vom: Mai, Seite 389-399  |h Online-Ressource  |w (DE-627)300595409  |w (DE-600)1483096-6  |w (DE-576)098134302  |x 1423-0232  |7 nnas  |a Efficacy and safety of autologous stem cell transplantation in first-line treatment and at relapse in elderly patients with multiple myeloma 
773 1 8 |g volume:103  |g year:2025  |g number:5  |g month:05  |g pages:389-399  |g extent:11  |a Efficacy and safety of autologous stem cell transplantation in first-line treatment and at relapse in elderly patients with multiple myeloma 
856 4 0 |u https://doi.org/10.1159/000541541  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20250613 
993 |a Article 
994 |a 2024 
998 |g 1387997181  |a Miah, Kaya  |m 1387997181:Miah, Kaya  |d 50000  |e 50000PM1387997181  |k 0/50000/  |p 3 
998 |g 1060031140  |a Sauer, Sandra  |m 1060031140:Sauer, Sandra  |d 910000  |d 910100  |e 910000PS1060031140  |e 910100PS1060031140  |k 0/910000/  |k 1/910000/910100/  |p 9  |y j 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |e 910000PG102258023X  |e 910100PG102258023X  |k 0/910000/  |k 1/910000/910100/  |p 8 
998 |g 141225688  |a Weinhold, Niels  |m 141225688:Weinhold, Niels  |d 910000  |d 910100  |d 50000  |e 910000PW141225688  |e 910100PW141225688  |e 50000PW141225688  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 7 
998 |g 1026849861  |a Bertsch, Uta  |m 1026849861:Bertsch, Uta  |d 910000  |d 910100  |e 910000PB1026849861  |e 910100PB1026849861  |k 0/910000/  |k 1/910000/910100/  |p 6 
998 |g 1023626950  |a Merz, Maximilian  |m 1023626950:Merz, Maximilian  |d 50000  |e 50000PM1023626950  |k 0/50000/  |p 5 
998 |g 106584686X  |a Benner, Axel  |m 106584686X:Benner, Axel  |d 50000  |e 50000PB106584686X  |k 0/50000/  |p 4 
999 |a KXP-PPN1928200109  |e 4733897189 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","given":"Eva-Maria","family":"Klein","display":"Klein, Eva-Maria"},{"role":"aut","given":"Sejla","display":"Hujic, Sejla","family":"Hujic"},{"display":"Miah, Kaya","family":"Miah","given":"Kaya","role":"aut"},{"display":"Benner, Axel","family":"Benner","role":"aut","given":"Axel"},{"family":"Merz","display":"Merz, Maximilian","role":"aut","given":"Maximilian"},{"family":"Bertsch","display":"Bertsch, Uta","given":"Uta","role":"aut"},{"role":"aut","given":"Niels","display":"Weinhold, Niels","family":"Weinhold"},{"given":"Hartmut","role":"aut","family":"Goldschmidt","display":"Goldschmidt, Hartmut"},{"role":"aut","given":"Sandra","display":"Sauer, Sandra","family":"Sauer"}],"language":["eng"],"origin":[{"dateIssuedDisp":"October 3, 2024","dateIssuedKey":"2025"}],"note":["Gesehen am 13.06.2025"],"title":[{"title_sort":"Efficacy and safety of autologous stem cell transplantation in first-line treatment and at relapse in elderly patients with multiple myeloma","title":"Efficacy and safety of autologous stem cell transplantation in first-line treatment and at relapse in elderly patients with multiple myeloma"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"disp":"Efficacy and safety of autologous stem cell transplantation in first-line treatment and at relapse in elderly patients with multiple myelomaOncology","type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"Oncology","subtitle":"international journal of cancer research and treatment","title_sort":"Oncology"}],"origin":[{"publisher":"Karger","dateIssuedKey":"1967","dateIssuedDisp":"1967-","publisherPlace":"Basel"}],"note":["Gesehen am 14.01.2019","Ungezählte Beil.: Supplement"],"pubHistory":["21.1967 -"],"id":{"issn":["1423-0232"],"zdb":["1483096-6"],"eki":["300595409"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"300595409","part":{"year":"2025","pages":"389-399","issue":"5","text":"103(2025), 5 vom: Mai, Seite 389-399","volume":"103","extent":"11"},"language":["eng"]}],"recId":"1928200109","name":{"displayForm":["Eva-Maria Klein, Sejla Hujic, Kaya Miah, Axel Benner, Maximilian Merz, Uta Bertsch, Niels Weinhold, Hartmut Goldschmidt, Sandra Sauer"]},"physDesc":[{"noteIll":"Illustrationen","extent":"11 S."}],"id":{"doi":["10.1159/000541541"],"eki":["1928200109"]}} 
SRT |a KLEINEVAMAEFFICACYAN3202